Medicare’s New Skin Substitute Reimbursement Rules Signal Increased Enforcement Risk
The Centers for Medicare & Medicaid Services (CMS) has implemented a fundamental change to how Medicare reimburses skin substitute products, effective January 1, 2026. While framed as a payment reform, the policy change carries significant compliance and enforcement implications for wound care clinics, physicians, suppliers, and manufacturers. For providers operating in the wound-care and regenerative […]
Skin Substitute and Wound Care Fraud Investigations: What Providers Need to Know in 2026
Skin substitutes and advanced wound care have quietly become one of the most aggressive enforcement areas in federal health care fraud. What began as civil audits and payment reviews has increasingly evolved into subpoenas, False Claims Act cases, and criminal investigations. I expect this trend to accelerate in 2026. In my practice, I am seeing […]